Scientists from the Florida campus of The Scripps Research
Institute (TSRI) have shown that a single protein plays an oversized role in
intellectual and behavioral development. The scientists found that mutations in
a single gene, which is known to cause intellectual disability and increase the
risk of developing autism spectrum disorder, severely disrupts the organization
of developing brain circuits during early childhood. This study helps explain
how genetic mutations can cause profound cognitive and behavioral problems.
The study was published in the Nov. 9, 2012, issue of the journal Cell.
The genetic mutations that cause developmental disorders, such as
intellectual disability and autism spectrum disorder, commonly affect synapses,
the junctions between two nerve cells that are part of the brain's complex
electro-chemical signaling system. A substantial percentage of children with
severe intellectual and behavioral impairments are believed to harbor single
mutations in critical neurodevelopmental genes. Until this study, however, it
was unclear precisely how pathogenic genetic mutations and synapse function
were related to the failure to develop normal intellect.
"In this study, we did something no one else had done
before," said Gavin Rumbaugh, a TSRI associate professor who led the new
research. "Using an animal model, we looked at a mutation known to cause
intellectual disability and showed for the first time a causative link between
abnormal synapse maturation during brain development and life-long cognitive
disruptions commonly seen in adults with a neurodevelopmental disorder."
Losing Balance
The study focused on a critical synaptic protein known as SynGAP1.
Mutations in the gene that encodes this protein cause disabilities in an
estimated one million people worldwide, according to the paper.
"There are a few genes that can't be altered without
affecting normal cognitive abilities," Rumbaugh said. "SynGAP1 is one
of the most important genes in cognition -- so far, every time a mutation that
disrupts the function of SynGAP1 has been found, that individual's brain simply
could not develop correctly. It regulates the development of synaptic function
like no other gene I've seen."
Using animal models that were missing just one copy of SynGAP1, as
seen in some patients with intellectual disability, the scientists found that
certain synapses develop prematurely in the period shortly after birth. This
dramatically enhances what is known as "excitability" -- how often
brain cells fire -- in the developing hippocampus, a part of the brain critical
for memory. The balance between excitability and inhibition is especially
critical during early developmental periods, when neural connections that
ultimately give rise to normal cognitive and behavioral functions are forming.
"You might think this accelerated development of brain
circuits would make you smarter," Rumbaugh said. "But the increased
excitability actually disorganizes brain development. We think that early
maturation of these excitatory synapses disrupts the timing of later
developmental milestones. It rains down chaos on this complex process,
preventing normal intellectual and behavioral development."
A Critical Window
Interestingly, inducing these mutations after the
critical development period was complete had virtually no impact on normal
synapse function and repairing these pathogenic mutations in adulthood did not
improve behavior or cognition.
"A key finding is we were able to remove the mutation and
restore SynGAP protein levels in adult mice with obvious cognitive and
behavioral problems, but this intervention did not benefit the animals,"
Rumbaugh said.
These results imply that very early intervention is essential in
neurodevelopmental disorders, particularly for cognitive problems. The team is
now aggressively searching for the optimal period during development in which
repairing these mutations is most beneficial.
Rumbaugh speculates that successfully defining these treatment
windows, combined with the fast-approaching ability to identify potential
pathogenic mutations in utero, will provide a possible path toward
eradicating this type of intellectual disability and lowering the risks for
autism. "We believe a cure is possible," he said. "It is likely
that there are many other single mutations out there that cause distinct forms
of these spectrum disorders. Our strategy could be applied to these disorders
as well."
The first author of the study, "Pathogenic SYNGAP1 Mutations
Impair Cognitive Development by Disrupting the Maturation of Dendritic Spine
Synapses," is James Clement of TSRI. Other authors include Massimiliano
Aceti, Thomas Creson, Emin D Ozkan, Brooke Miller, and Courtney A. Miller of
TSRI; Yulin Shi and Xiangmin Xu of The University of California, Irvine;
Nicholas Reis and Antoine Almonte of The University of Alabama at Birmingham;
and Brian Wiltgen of The University of Virginia.
The study was funded by the National Institute for Neurological
Disorders and Stroke (R01NS064079), the Eunice Kennedy Shriver National
Institute for Child Health and Human Development (R03HD060672), the National
Alliance for Research on Schizophrenia and Depression, and the National
Institute for Drug Abuse (DA023700-04S1).
Journal Reference:
1. James P. Clement, Massimiliano Aceti,
Thomas K. Creson, Emin D. Ozkan, Yulin Shi, Nicholas J. Reish,
Antoine G. Almonte, Brooke H. Miller, Brian J. Wiltgen,
Courtney A. Miller, Xiangmin Xu, Gavin Rumbaugh. Pathogenic
SYNGAP1 Mutations Impair Cognitive Development by Disrupting Maturation of
Dendritic Spine Synapses.Cell, 2012; 151 (4): 709 DOI: 10.1016/j.cell.2012.08.045
0 comments:
Post a Comment